(NASDAQ: AIRS) Airsculpt Technologies's forecast annual revenue growth rate of 3.19% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.33%.
Airsculpt Technologies's revenue in 2026 is $150,724,000.On average, 5 Wall Street analysts forecast AIRS's revenue for 2026 to be $11,264,876,406, with the lowest AIRS revenue forecast at $10,795,536,596, and the highest AIRS revenue forecast at $11,650,585,774. On average, 5 Wall Street analysts forecast AIRS's revenue for 2027 to be $11,539,559,153, with the lowest AIRS revenue forecast at $11,046,427,923, and the highest AIRS revenue forecast at $11,945,455,179.
In 2028, AIRS is forecast to generate $11,913,012,335 in revenue, with the lowest revenue forecast at $11,339,855,424 and the highest revenue forecast at $12,377,305,481.